急性および慢性創傷管理のためのカルキュミンを含む薬剤投与システム:レビュー
Xiaoxuan Deng1, Jithendra Ratnayake2, Azam Ali1,2
1Centre for Bioengineering & Nanomedicine (Dunedin), Faculty of Dentistry, Division of Sciences, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand.
Bioengineering (Basel, Switzerland)
|August 28, 2025
まとめ
カルキュミンは 抗酸化剤と抗炎症剤で 慢性的な傷の治癒を 促進する効果があります カルクミンに富んだ包帯は 組織修復を促すため 制御された出血を可能にします
科学分野:
- バイオメディカルエンジニアリング
- 薬理学について
- 材料科学
背景:
- 傷の治癒には 異なる生理学的段階があります 血静 炎症 増殖 そして再形成です
- 慢性的な傷は 炎症と感染が長引くため 治癒を阻害し 臨床的な課題を提起します
- 有効な慢性創傷管理には,創傷ケア技術と治療薬を組み合わせた統合的なアプローチが必要です.
研究 の 目的:
- 急性および慢性的な傷の病理生理学と管理を含む傷の治癒の生理学をレビューする.
- カルキュミンの生物学的活動を調査し,組織修復を促進する役割に焦点を当てます.
- 傷の治癒を向上させるため,カルキュミンを含んだ先進的な配送システムを試験する.
主な方法:
- 創傷治癒の生理学と病理学に関する包括的な文献レビュー.
- 抗酸化,抗炎症,抗菌効果を含むクルクミンの生物学的性質の分析
- カルキュミンを含有する様々なドレッシング製剤 (水素ゲル,ナノ繊維膜,ミセル,フィルム) の調査.
主要な成果:
- カルキュミンは,傷の治癒に有益な重要な抗酸化,抗炎症,抗菌性を持っています.
- カルキュミンは組織修復を加速し,炎症の解消を促進する可能性を示しています.
- カルクミンに富んだ包帯は,制御された放出と標的の投与を促進し,治療効果を最適化します.
結論:
- カルキュミンは重篤な傷の治療に 重要な治癒経路を調節することで 治療的な可能性を秘めています
- 先進的な薬剤投与システムは 傷の治癒におけるカルキュミンの有効性を最大化するために不可欠です
- カルキュミンベースの治療法と投与システムに関するさらなる研究は,傷の治療における臨床結果の改善につながる可能性があります.
さらに関連する動画
09:17Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
421
08:39Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
Published on: July 4, 2017
9.0K
関連する概念動画
01:28Phases of Wound Repair
6.3K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
6.3K
01:22Drug Delivery: Miscellaneous Routes
467
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
467
01:16Drug Delivery: Overview
422
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
422
01:15Non-Oral Extravascular Drug Absorption Routes
294
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
294
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
595
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
595
01:29Drug Delivery: Parenteral Route
827
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
827